We have set up our new Discord server! Share your feedback and find like-minded people! Join our Discord

Ticker
ASND

Price
150.99
Stock movement up
+7.66 (5.34%)
Company name
Ascendis Pharma AS
Exchange
(NASDAQ
,
Currency
USD
)
Sector
Healthcare >
Biotechnology
Market cap
9.02B
Ent value
9.59B
Price/Sales
39.97
Price/Book
-
Div yield
-
Div growth
-
Growth years
-
FCF payout
-
Trailing P/E
-
Forward P/E
-
PEG
-
EPS growth
21.99%
1 year return
-1.04%
3 year return
8.68%
5 year return
4.39%
10 year return
23.99%
Last updated: 2025-04-11

iO Charts is a Seeking Alpha partner

DIVIDENDS

ASND does not pay dividends or no data was received

iO Charts is a Seeking Alpha partner

VALUATION

Valuation Ratios

Loading...
Valuation Ratios data
Trailing P/E-
Price to OCF-
Price to FCF-
Price to EBITDA-
EV to EBITDA-

Valuation (Sales/Book Value)

Loading...
Valuation (Sales/Book Value) data
Price to Sales39.97
Price to Book-
EV to Sales42.48

iO Charts is a Seeking Alpha partner

iO Charts is a Seeking Alpha partner

FINANCIALS

Per share

Loading...
Per share data
Current share count59.76M
EPS (TTM)-7.51
FCF per share (TTM)-2.41

Income statement

Loading...
Income statement data
Revenue (TTM)225.72M
Gross profit (TTM)184.02M
Operating income (TTM)-412.40M
Net income (TTM)-448.99M
EPS (TTM)-7.51
EPS (1y forward)-3.39

Margins

Loading...
Margins data
Gross margin (TTM)81.53%
Operating margin (TTM)-182.70%
Profit margin (TTM)-198.91%

Balance Sheet

Loading...
Please create a free account or log in to access this chart
Balance Sheet data
Cash625.51M
Net receivables50.35M
Total current assets973.74M
Goodwill0.00
Intangible assets0.00
Property, plant and equipment0.00
Total assets1.09B
Accounts payable75.27M
Short/Current long term debt788.66M
Total current liabilities838.46M
Total liabilities1.19B
Shareholder's equity-97.32M
Net tangible assets0.00

Cash flow

Loading...
Please create a free account or log in to access this chart
Cash flow data
Operating cash flow (TTM)-162.89M
Capital expenditures (TTM)541.00K
Free cash flow (TTM)-144.31M
Dividends paid (TTM)0.00

Financial returns

Loading...
Please create a free account or log in to access this chart
Financial returns data
Return on Equity-
Return on Assets-41.05%
Return on Invested Capital-64.95%
Cash Return on Invested Capital-20.87%

iO Charts is a Seeking Alpha partner

STOCK INFORMATION

Stock chart

Loading...
Stock price data
Open144.10
Daily high153.34
Daily low142.18
Daily Volume426K
All-time high182.76
1y analyst estimate191.67
Beta0.65
EPS (TTM)-7.51
Dividend per share-
Ex-div date-
Next earnings date30 Apr 2025

Downside potential

Loading...
Downside potential data
ASNDS&P500
Current price drop from All-time high-17.38%-12.89%
Highest price drop-61.72%-56.47%
Date of highest drop28 Apr 20239 Mar 2009
Avg drop from high-20.17%-11.07%
Avg time to new high30 days12 days
Max time to new high1087 days1805 days

iO Charts is a Seeking Alpha partner

iO Charts is a Seeking Alpha partner

COMPANY DETAILS
ASND (Ascendis Pharma AS) company logo
Marketcap
9.02B
Marketcap category
Mid-cap
Description
Ascendis Pharma A/S, a biopharmaceutical company, focuses on developing therapies for unmet medical needs. It offers SKYTROFA for treating patients with growth hormone deficiency (GHD). The company is also developing a pipeline of three independent endocrinology rare disease product candidates in clinical development, as well as focuses on advancing oncology therapeutic candidates. The company was incorporated in 2006 and is headquartered in Hellerup, Denmark.
Employees
879
Investor relations
-
SEC filings
CEO
Jan Møller Mikkelsen
Country
USA
City
Hellerup
Stock type
American depositary share
CCC status
-
Dividend Frequency
-
EVENTS AND PRESENTATIONS
EventsPresentations
Loading...

iO Charts is a Seeking Alpha partner

iO Charts is a Seeking Alpha partner

UNDERSTAND THE BUSINESS
Loading...